• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Manufacturing
    • Packaging
    • Development
    • Compliance
    • Top 25
    • Directory
    • Microsites
    • Events
    • More
  • Magazine
  • News
  • Manufacturing
  • Packaging
  • Development
  • Compliance
  • Top 25
  • Directory
  • Microsites
  • Events
  • Current / Back Issue
    Features
    Editorial
    Columns
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Subscribe Now
    Advertise Now
    Top Features
    Pharmaceutical Packaging Technology

    Elemental Impurities: The Time Has Come

    Continuous vs. Batch Production

    2018: The evolution of pharmaceutical packaging

    Formulation Development Trends
    Breaking News
    Online Exclusives
    Industry News
    Collaborations & Alliances
    Promotions & Moves
    Trials & Filings
    Financial Reports
    Bio News & Views
    Custom Sourcing News
    Packaging & Tracking
    CRO News
    Live From Shows
    Top News
    Sterling Pharma Invests £6M To Expand Offerings

    Bioclinica Announces Key Hires & Promotion

    PhoenixMD, STA Enter Manufacturing Agreement

    ProBioGen, Tizona Therapeutics Enter Collaboration

    Mayne Pharma Opens $80M Oral Solid Dose Facility
    APIs
    Aseptic Processing
    Cleaning Validation
    Clinical Trial Materials
    Cytotoxics and High Potency Manufacturing
    Equipment
    Excipients
    Extractables and Leachables
    Facilities
    Fill/Finish
    Lyophilization
    Parenterals
    Process Development
    Process Validation
    Risk Management
    Scale-up/ Technology Transfer
    Solid Dosage/ Creams/ Ointments

    Arcinova Receives £1.5M Innovate UK Grant

    Vetter Announces Visit from Illinois Governor

    Sterling Pharma Invests £6M To Expand Offerings

    PhoenixMD, STA Enter Manufacturing Agreement

    Mayne Pharma Opens $80M Oral Solid Dose Facility
    Capsules
    Cold Chain Management
    Injectables
    Logistics
    Serialization
    Solid Dosage / Semi-solids
    Supply Chain
    Vials

    INTERPHEX: Adents Showcases Cloud-Based Serialization Solution

    Almac Group Expands Packaging Capabilities

    Catalent Bolsters Clinical Supply Capabilities

    West, Stevanato Group Enter Ompi EZ-fill Alliance

    Pharmaceutical Packaging Technology
    Analytical Services
    Bioanalytical Services
    Bioassay Developement
    Biologics, Proteins, Vaccines
    Biosimilars
    Chemistry
    Clinical Trials
    Drug Delivery
    Drug Development
    Drug Discovery
    Formulation Development
    Information Technology
    Laboratory Testing
    Methods Development
    Microbiology
    Preclinical Outsourcing
    R&D
    Toxicology

    Sterling Pharma Invests £6M To Expand Offerings

    PhoenixMD, STA Enter Manufacturing Agreement

    ProBioGen, Tizona Therapeutics Enter Collaboration

    INTERPHEX: Adents Showcases Cloud-Based Serialization Solution

    SAMDI Tech Enters Drug Discovery Collaboration
    Filtration & Purification
    GMPs/GCPs
    Inspections
    QA/QC
    Regulatory Affairs
    Validation

    Blockchain: The Next Big Trend in BioPharma?

    Emergent Completes Market Authorization

    Technical and Regulatory Considerations for Pharmaceutical Product Lifecycle: ICH Q12

    LSNE Expands Capabilities and QC Laboratory Space

    Evotec Launches Drug Development Service
    Companies
    Categories
    Corporate Capabilities
    Add New Company
    Contract Service Directory Companies
    Avid Bioservices, Inc.

    Fusion Scientific Laboratories

    Apex Graphics Inc.

    Symbiosis Pharmaceutical Services

    Avista Pharma Solutions
    Companies
    News Releases
    Posters
    Brochures
    Services
    Videos
    Case Study
    White Papers
    Jobs
    Contract Service Directory Companies
    Alcami
    Webinars
    Live From Shows
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • Enewsletter Archive
      • Digital Edition
    • Directory
      • Companies
      • Categories
      • Corporate Capabilities
      • Add Your Company
    • Manufacturing
      • APIs
      • Aseptic Processing
      • Cleaning Validation
      • Clinical Trial Materials
      • Cytotoxics and High Potency Manufacturing
      • Equipment
      • Excipients
      • Extractables and Leachables
      • Facilities
      • Fill/Finish
      • Lyophilization
      • Parenterals
      • Process Development
      • Process Validation
      • Risk Management
      • Scale-up/ Technology Transfer
      • Solid Dosage/ Creams/ Ointments
      • cGMP Manufacture
    • Packaging
      • Capsules
      • Cold Chain Management
      • Injectables
      • Logistics
      • Serialization
      • Solid Dosage / Semi-solids
      • Supply Chain
      • Vials
    • Development
      • Analytical Services
      • Bioanalytical Services
      • Bioassay Developement
      • Biologics, Proteins, Vaccines
      • Biosimilars
      • Chemistry
      • Clinical Trials
      • Drug Delivery
      • Drug Development
      • Drug Discovery
      • Formulation Development
      • Information Technology
      • Laboratory Testing
      • Methods Development
      • Microbiology
      • Preclinical Outsourcing
      • R&D
      • Toxicology
    • Compliance
      • Filtration & Purification
      • GMPs/GCPs
      • Inspections
      • QA/QC
      • Regulatory Affairs
      • Validation
    • Top 25 Pharma & BioPharma
      • Top 20 Pharma & BioPharma
      • Top 10 BioPharma Companies
    • Breaking News
    • Online Exclusives
    • Slideshows
    • Experts Opinions
    • Surveys
      • Outsourcing Survey
      • Salary Survey
    • Glossary
    • Videos
    • White Papers
    • Infographics
    • Supplier Microsite
      • Companies
      • News Releases
      • Posters
      • Brochures
      • Services
      • Videos
      • Case Study
      • White Papers
    • Contract Pharma Conference
      • Contract Pharma Conference
      • Speakers
      • Exhibitors
      • Agenda
      • Conference Sessions
    • Events
      • Industry Events
      • Live from Show Events
      • Webinars
    • Classifieds / Job Bank
      • Classifieds
      • Job Bank
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Breaking News

    Sygnature Discovery Invests in New Start-up

    Partnership with Peak Proteins adds protein production and crystallography to range of drug discovery capabilities

    Related CONTENT
    • Cobra Biologics Invests $19m in Gene Therapy Mfg. Expansion
    • Domain, Pfizer in bioSensAll Alliance
    • Recipharm Delivers First Serialized Batch to Saudi Arabia
    • AMRI Wins Five-Year NIH Contract
    • Overcoming Preclinical Drug Development Hurdles
    01.26.16
    Sygnature Discovery, a UK provider of integrated drug discovery resource and expertise has invested, through its parent Sygil Group, in a new start-up company, Peak Proteins. The investment in Peak Proteins is part of an on-going strategy to build and expand the group’s capabilities. The deal, which was signed in December 2015, sees Sygil making a significant financial investment in the BioHub-based business at Alderley Park, Cheshire, UK. This partnership with Peak Proteins adds protein production and crystallography to Sygnature’s current range of drug discovery capabilities.

    Peak Proteins was founded by Mark Abbott in 2014 and has been trading since summer 2015. Collectively, the experienced ex-AstraZeneca team provides engineered, tailored protein reagents and 3D atomic level structures of proteins using X-ray crystallography to enable the rational design of new drugs.

    “Computational structure-based design is a very important part of modern drug discovery and Peak Proteins’ team of highly experienced scientists offer a rare skill set in protein crystallography, which compliments and supports our existing capabilities,” said Simon Hirst, founder and chief executive officer, Sygnature Discovery. “This is much more than a financial investment as we will be able to share our management expertise with Peak Proteins and support their future growth.”

    He continued, “Our involvement means that we can now offer protein production and crystallography alongside our client projects, or separately, and this expands our capabilities further. The two companies will also be able to work together to develop new services and technologies that will be advantageous to our clients.”

    “It is great to have the expertise and involvement of Simon and his team at Sygnature Discovery,” said Mark Abbott, founder, Peak Proteins. “There is a lot we can learn from their successes as we grow our business. Working together in this way will give us the necessary cash injection to accelerate our growth as well as making some important capital investments in equipment.”
    Related Searches
    • integrated drug discovery
    • discovery
    • equipment
    • chief executive officer
    Suggested For You
    KBI Biopharma Invests $30M in Facility Upgrades KBI Biopharma Invests $30M in Facility Upgrades
    XOMA Earns $10M Milestone  XOMA Earns $10M Milestone
    Cambrex Invests to Increase Pilot Scale API Capacity Cambrex Invests to Increase Pilot Scale API Capacity
    PCI Begins Move-In Phase of European Clinical Site Expansion PCI Begins Move-In Phase of European Clinical Site Expansion
    Sanofi and Exscientia Pen €250M Drug Discovery Deal Sanofi and Exscientia Pen €250M Drug Discovery Deal
    Sharp announces £9 million investment in European Clinical Services Centre of Excellence Sharp announces £9 million investment in European Clinical Services Centre of Excellence
    Patheon Completes NC Sterile Expansion  Patheon Completes NC Sterile Expansion
    Sartorius Stedim Biotech Launches Chemistry Testing Services Sartorius Stedim Biotech Launches Chemistry Testing Services
    Overcoming Preclinical Drug Development Hurdles Overcoming Preclinical Drug Development Hurdles
    AMRI Wins Five-Year NIH Contract AMRI Wins Five-Year NIH Contract
    Recipharm Delivers First Serialized Batch to Saudi Arabia Recipharm Delivers First Serialized Batch to Saudi Arabia
    Domain, Pfizer in bioSensAll Alliance   Domain, Pfizer in bioSensAll Alliance
    Cobra Biologics Invests $19m in Gene Therapy Mfg. Expansion Cobra Biologics Invests $19m in Gene Therapy Mfg. Expansion

    Related Breaking News

    • Bio News | Collaborations & Alliances | Industry News
      ProBioGen, Tizona Therapeutics Enter Collaboration

      ProBioGen, Tizona Therapeutics Enter Collaboration

      To develop immune system centered treatments for cancer
      04.18.18

    • Breaking News | Collaborations & Alliances | Industry News
      SAMDI Tech Enters Drug Discovery Collaboration

      SAMDI Tech Enters Drug Discovery Collaboration

      Forms partnership with Enamine to expand small molecule compound libraries
      04.17.18

    • Bio News | Collaborations & Alliances | Industry News
      Telix, INSERM, and ARRONAX Enter Agreement

      Telix, INSERM, and ARRONAX Enter Agreement

      To explore the feasibility of using several of Telix's clinical targeting agents with astatine
      04.16.18


    • Bio News | Collaborations & Alliances | Industry News
      Idera, Pillar Partners Enter Agreement

      Idera, Pillar Partners Enter Agreement

      Pillar Partners will provide funding to support three clinical trials to expand the clinical research of Idera's IMO-2125
      04.16.18

    • Bio News | Collaborations & Alliances | Industry News
      Kineta, Genentech Enter Collaboration

      Kineta, Genentech Enter Collaboration

      To develop Kineta's α9/α10 nicotinic acetylcholine receptor (nAChR) antagonists for the treatment of chronic pain
      04.16.18

    • Bio News | Collaborations & Alliances | Facilities | Industry News
      Sartorius Stedim Biotech, Penn State Enter Partnership

      Sartorius Stedim Biotech, Penn State Enter Partnership

      To support the education and preparation of the next generation of biotechnology leaders
      04.16.18


    • Bio News | Collaborations & Alliances | Industry News | Trials & Filings
      Argenx Achieves Preclinical Milestone

      Argenx Achieves Preclinical Milestone

      In its collaboration with LEO Pharma, for ARGX-112
      04.12.18

    • Industry News | Promotions & Moves
      Selexis Installs $2M in New Lab Equipment

      Selexis Installs $2M in New Lab Equipment

      The company also made key strategic hires and signed its one hundredth commercial license agreement (CLA)
      04.12.18

    • Bio News | Collaborations & Alliances | Industry News
      GSK, Orchard Therapeutics Enter Strategic Agreement

      GSK, Orchard Therapeutics Enter Strategic Agreement

      GSK will transfer its portfolio of approved and investigational rare disease gene therapies to Orchard
      04.12.18


    • Bio News | Breaking News | Industry News | Regulatory Affairs
      Emergent Completes Market Authorization

      Emergent Completes Market Authorization

      For BioThrax (Anthrax Vaccine Adsorbed) in five Concerned Member States (CMS) within the European Union (EU)
      04.12.18

    • Bio News | Collaborations & Alliances | Facilities | Industry News
      MilliporeSigma, Oxford University Enter Partnership

      MilliporeSigma, Oxford University Enter Partnership

      To develop a vaccine manufacturing facility in Ghana and to expand their scalable vaccine manufacturing processes
      04.12.18

    • Bio News | Breaking News | Industry News | Trials & Filings
      FDA Approves Novartis’ Afinitor

      FDA Approves Novartis’ Afinitor

      For the treatment of adult and pediatric patients with tuberous sclerosis complex with associated partial onset seizures
      04.11.18

    • Bio News | Collaborations & Alliances | Industry News
      Zealand, Roche Diabetes Care Enter Collaboration

      Zealand, Roche Diabetes Care Enter Collaboration

      For the Phase 3 trials with dasiglucagon for treatment of congenital hyperinsulinism (CHI)
      04.11.18

    • Bio News | Collaborations & Alliances | Industry News
      Inovio, CEPI Enter Partnership

      Inovio, CEPI Enter Partnership

      Inovio will develop vaccine candidates against Lassa fever and Middle East Respiratory Syndrome
      04.11.18

    • Bio News | Breaking News | Collaborations & Alliances | Industry News
      Novartis Inks $8.7B Deal to Acquire AveXis

      Novartis Inks $8.7B Deal to Acquire AveXis

      Novartis will pay $218 a share of AveXis in cash, an 88% premium to its closing price on April 6
      04.10.18

    Breaking News
    • Sterling Pharma Invests £6M To Expand Offerings
    • AGC Chemicals to Feature Advanced Intermediates
    • Avema to Showcase Range of Services
    • Peter Stein to Deliver FDA Keynote Presentation
    • CPhI NA Conference to Focus on Fostering Innovation
    View Breaking News >
    CURRENT ISSUE

    April 2018

    • Pharmaceutical Packaging Technology
    • Elemental Impurities: The Time Has Come
    • Continuous vs. Batch Production
    • 2018: The evolution of pharmaceutical packaging
    • Formulation Development Trends
    • Changing Dynamics: The CDMO market in focus
    • Contract BioManufacturing in China: Creating a New Segment
    • View More >

    Copyright © 2018 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.